P103 - Efficacy and Safety of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, in Patients with Type 1Diabetes and Chronic Kidney Disease: A Post-Hoc Analysis of the inTandem Studies
P104 - Impact of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin-Treated Type 2 Diabetes
P108 - Ongoing Treatments with High Concentration Capsaicin Topical System Results in Progressive Pain Reduction for Painful Diabetic Neuropathy: A Retrospective Real-World Analysis
P112 - Once-Weekly Basal Insulin Efsitora Alfa Demonstrates Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With T2D: Results from Phase 2